GSK-626616 (Standard) is the analytical standard of GSK-626616 ( HY-105309 ). This product is intended for research and analytical applications. GSK-626616 is a potent, orally bioavailable inhibitor of DYRK3 (IC 50 =0.7 nM). GSK-626616 inhibits other members of the DYRK family (e.g., DYRK1A and DYRK2 ) with similar potency, which is a potential therapy for the treatment of anemia.
Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > DYRK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.